Plunkett Research Online: China Biologic Products Inc

CHINA BIOLOGIC PRODUCTS INC (CBPO:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

China Biologic Products, Inc. (CBPO.OB) through its indirect majority-owned subsidiary, Shandong Taibang, and equity investments in Xi'an Huitian and Chongqing Dalin, is currently the largest non-state-owned plasma-based biopharmaceutical company approved by the Chinese government. The company is a.....



China Biologic Products Inc
Ticker: CBPO
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 86 1065983111
Fax:
Address: 19 Chaoyang Park Road
1801, Jialong International Building
Chaoyang District
Beijing, 100125 China

Types Of Business
Industry Ranks

Industry NAICS code:

Blood Plasma Technologies
ContactsDescription
David GaoCEO/Chairman of the Board/Director/President
Ming YangCFO/Chief Accounting Officer
See More
China Biologic Products, Inc. (CBPO.OB) through its indirect majority-owned subsidiary, Shandong Taibang, and equity investments in Xi'an Huitian and Chongqing Dalin, is currently the largest non-state-owned plasma-based biopharmaceutical company approved by the Chinese government. The company is a.....See More See More

Auditor: KPMG Huazhen
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
NameTitleSalary (US$)Bonus (US$)
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: